Plasma inflammatory proteins and transcriptome profiles of neutrophils in COPD patients with PiMM and PiZZ alpha1antitrypsin treated or non-treated with augmentation therapy

被引：0

作者：

Lechowicz, Urszula ^{[1
]}

Zdral, Aneta ^{[1
]}

Rozy, Adriana ^{[1
]}

Szpechcinski, Adam ^{[1
]}

Martinez-Delgado, Beatriz ^{[2
]}

Olejnicka, Beata ^{[3
,4
]}

Janciauskiene, Sabina ^{[3
,4
,5
]}

Chorostowska-Wynimko, Joanna ^{[1
]}

机构：

[1] Natl Inst TB & Lung Dis, Dept Genet & Clin Immunol, Warsaw, Poland

[2] Spanish Natl Inst Hlth Carlos III ISCIII, Inst Rare Dis Res IIER, Mol Genet Unit, Madrid, Spain

[3] Biomed Res Endstage & Obstruct Lung Dis Hannover, Dept Resp Med, Hannover, Germany

[4] German Ctr Lung Res DZL, Hannover, Germany

[5] Dept Genet & Clin Immunol, Hannover, Germany

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

Inflammation; COPD; Biomarkers;

D O I：

10.1183/13993003.congress-2023.PA2344

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：2

共 6 条

[1] Plasma acute phase proteins with specific emphases on alpha1-antitrypsin polymers and transcriptome of blood neutrophils in PiMM and PiZZ COPD patients
Wrenger, S.
Lechowicz, U.
Liu, B.
Martinez-Delgado, B.
Welte, T.
Chorostowska, J.
Janciauskiene, S.
PNEUMOLOGIE, 2024, 78 : S63 - S63
[2] Adhesion ratio of blood neutrophils from PiZZ COPD patients prior to and during augmentation treatment with alpha-1-antitrypsin
Lechowicz, Urszula
Rudzinski, Stefan
Rozy, Adriana
Chorostowska-Wynimko, Joanna
Janciauskiene, Sabina
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[3] Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy
Olfert, I. Mark
Malek, Moh H.
Eagan, Tomas M. L.
Wagner, Harrieth
Wagner, Peter D.
BMC PULMONARY MEDICINE, 2014, 14
[4] Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients ‘on’ or ‘off’ augmentation therapy
I Mark Olfert
Moh H Malek
Tomas ML Eagan
Harrieth Wagner
Peter D Wagner
BMC Pulmonary Medicine, 14
[5] Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy
Carlos Barros-Tizon, Juan
Luisa Torres, Maria
Blanco, Ignacio
Teresa Martinez, Maria
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (02) : 67 - 78
[6] Retrospective analysis of COPD exacerbations in patients treated with alpha1-proteinase inhibitor augmentation therapy
Romberg, Val
Hubsch, Alphonse
CHEST, 2006, 130 (04) : 184S - 184S

← 1 →